| Literature DB >> 36001592 |
Angela M Stover1,2, Mian Wang2, Christopher M Shea1,3, Erica Richman3, Jennifer Rees4, Andrea L Cherrington5, Doyle M Cummings6, Liza Nicholson7, Shannon Peaden6, Macie Craft5, Monique Mackey8, Monika M Safford9, Jacqueline R Halladay3,10.
Abstract
BACKGROUND: Practice facilitators (PFs) provide tailored support to primary care practices to improve the quality of care delivery. Often used by PFs, the "Key Driver Implementation Scale" (KDIS) measures the degree to which a practice implements quality improvement activities from the Chronic Care Model, but the scale's psychometric properties have not been investigated. We examined construct validity, reliability, floor and ceiling effects, and a longitudinal trend test of the KDIS items in the Southeastern Collaboration to Improve Blood Pressure Control trial.Entities:
Mesh:
Year: 2022 PMID: 36001592 PMCID: PMC9401114 DOI: 10.1371/journal.pone.0272816
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Parent study synopsis.
|
| Southeastern Collaboration to Improve Blood Pressure Control Trial |
|
| NCT02866669 |
|
| Pragmatic, cluster-randomized trial with 4 arms: |
|
| 69 |
|
| 32 |
|
| Alabama and North Carolina |
|
| 4 (2 PFs worked with 18 practices in Alabama and 2 PFs worked with 14 practices in North Carolina) |
|
| Change in hypertension control by study arm at 12 months |
|
| • Primary Care practice located in Alabama or North Carolina |
EHR: electronic health record, PFs: practice facilitators
KDIS items and response options.
| KDIS Item | Construct(s) Assessed | Response Options |
|---|---|---|
| Clinical Information System | Extent to which a practice uses data from their electronic health record or registry for population health management | 0 = Practice currently does not review practice population data, such as a report that shows how many patients have hypertension or how many have it under control. |
| 1 = Practice has access to reliable data on their patients with hypertension (for example, all patients with hypertension and their average BP, or the % of hypertension patients that have BP <140/90) | ||
| 2 = The practice trusts their BP data / reports enough to consider implementing change activities | ||
| 3 = The practice accesses and reviews BP data monthly and discusses how to make changes to improve processes to optimize BP control | ||
| Optimized Team Care | Extent to which practice team members share workloads for patient care and quality improvement activties | 0 = No QI activities related to hypertension currently |
| 1 = Occasional meetings or discussions regarding QI for hypertension but no practice-wide understanding of QI | ||
| 2 = A QI team communicates regularly (through meetings, huddles, emails, memos, etc.) to plan tests and discuss results of hypertension QI. QI team can describe project focus and measures. | ||
| 3 = A QI team is planning and discussing multiple tests simultaneously to improve HTN control, and communicates findings to each other. QI progress is communicated to entire office staff. Most staff can describe QI focus and measures. | ||
| Standardized Care Processes | Extent to which a practice uses evidence-based or informed protocols to standardize treatment | 0 = The practice currently has no activity on following evidence based protocols for hypertension. |
| 1 = The practice has identified one or more evidence-base or best practice protocol(s) for hypertension, and has begun the process of customizing one or more protocols for their own practice to guide care for their patients with high blood pressure. | ||
| 2 = The practice has established a workflow to support implementing at least one hypertension protocol and it has been tested on at least a few patients. | ||
| 3 = The practice has implemented an evidence-based protocol for hypertension, but it is not yet being used with all patients. | ||
| 4 = The practice routinely fully implements and follows at least one evidence-based protocol for hypertension. | ||
| Self-Management Support | Extent to which a practice uses resources to enable patients to self-manage their health condition | 0 = Practice currently has no activity on self-management support for patients with hypertension |
| 1 = Practice staff understands the difference between patient education and self-management support | ||
| 2 = Practice identifies hypertension related SMS resources and incorporates the use of the resources into their workflow | ||
| 3 = Practice develops tracking systems to monitor use of hypertension related SMS resources. | ||
| 4 = The care team 1) collaborates with patients to set hypertension related self-management goals, 2) documents the goals, and 3) reviews previous goals at every visit. | ||
| 5 = Care team assess patients’ confidence level related to | ||
| managing their hypertension. | ||
| Leadership | Extent to which a practice has leadership support for quality improvement activities | 0 = No management or leadership support for QI work in hypertension currently exists.| |
| 1 = A single manager or physician champion is involved but no organized QI structure for hypertension exists. “Try and see approach” is the norm for QI activities related to hypertension. | ||
| 2 = The practice has a leader who supports hypertension QI activities and there are some tasks that are assigned to staff members. | ||
| 3 = QI work for hypertension is integrated into daily routines and there are certain staff who are assigned QI activities. |
BP: blood pressure, HTN: hypertension, SMS: self-management support, QI: quality improvement
Overview of psychometric analyses.
| Psychometric Characteristic | Statistical Test | What Test Tells Us |
|---|---|---|
| Responsiveness | Trend test: Random-intercept linear mixed model with autoregressive residual correlations, treating practice facilitators as clusters | Whether the data shows a statistical trend of increasing scores over time for each KDIS item, and the expected number of months for a practice to move to the highest response options |
| Floor or Ceiling Effects | Percent of practices in each month scoring zero or the highest response option (low variability in scores) | Floor effects show the percentage of practices scoring consistently at the lowest response option (zero), and ceiling effects indicate the percent of practices scoring consistently at the top of the scale. |
| Factorial Validity | Multilevel confirmatory factor analysis | Whether the KDIS items measure one or more distinct groups of implementation activities |
| Reliability | Estimated within the multilevel framework | Whether the scale consistently yields same result |
KDIS: Key Driver Implementation Scale
Fig 1SEC trial CONSORT diagram for primary care practices.
Fig 2a. Clinical Information System Item Averages for Each Practice Facilitator. b. Optimized Team Care Item Averages for Each Practice Facilitator. c. Standardized Care Processes Item Averages for Each Practice Facilitator. d. Self-Management Support for Patients Item Averages for Each Practice Facilitator. e. Leadership Support Item Averages for Each Practice Facilitator.
Fig 3a. Floor Effects by Month. b. Ceiling Effects by Month.
Longitudinal trend test results for KDIS items.
| KDIS Item | Response Options | Intercept: Average Starting Score for Practices | Slope: Expected Increase in Score Every Month | Degrees of Freedom | t-value | Estimated # of Months to Move to Highest Score |
|---|---|---|---|---|---|---|
| Clinical Information System | 0 = Practice currently does not review practice population data, such as a report that shows how many patients have hypertension or how many have it under control. | 1.266 | 0.170 | 364 | 18.091*** | 10.2 months |
| Optimized Team Care | 0 = No QI activities related to hypertension currently | 1.068 | 0.135 | 361 | 14.589*** | 14.3 months |
| Standardized Care Processes | 0 = The practice currently has no activity on following evidence based protocols for hypertension. | 1.467 | 0.279 | 356 | 19.95*** | 9.1 months |
| Self-Management Support | 0 = Practice currently has no activity on self-management support for patients with hypertension | 1.107 | 0.308 | 362 | 25.734*** | 12.6 months |
| Leadership | 0 = No management or leadership support for QI work in hypertension currently exists.| | 1.244 | 0.134 | 363 | 13.225*** | 13.1 months |
***p < .001
BP: blood pressure, HTN: hypertension, QI: quality improvement
Fig 4Expected trajectory for KDIS items.
Multilevel confirmatory factor analysis model comparisons by state.
| Alabama | North Carolina | |
|---|---|---|
|
| ||
| Alpha | 0.724 | 0.716 |
| Omega (composite reliability) | 0.744 | 0.699 |
|
| ||
| Chi-Square Test of Model Fit | X2 = 2.898 | X2 = 1.724 |
| df = 5 | df = 5 | |
| p = 0.716 | p = 0.886 | |
| RMSEA <0.06 | 0.000 | 0.000 |
| CFI >0.95 | 1.00 | 1.00 |
| TLI >0.95 | 1.192 | 1.288 |
| WRMR <1.0 | 0.173 | 0.068 |
| SRMR within factors <0.08 | 0.133 | 0.085 |
|
| ||
| Clinical Information System | 0.540 | 0.824 |
| Optimized Team Care | 0.705 | 0.881 |
| Standardized Care Processes | 0.812 | 0.663 |
| Patient self-management support | 0.987 | 0.346 |
| Leadership support | 0.601 | 0.997 |
* = Test is used to reject a null hypothesis representing perfect fit, and thus the ideal p-value is not significant.
RMSEA = root mean squared error of approximation
CFI = Confirmatory fit index
TLI = Tucker Lewis Index
WRMR = weighted root mean square residual
SRMR = Standardized root mean square residual
Recommendations and future research agenda.
| Recommendations | Rationale |
|---|---|
| Future Trial Design Considerations | |
| Add an independent practice rater that evaluates practices on a monthly basis independently of PFs | Examine inter-rater reliability of the KDIS items |
| Consider increasing the time for PFs to actively work with practices from 12 months to 14 months when feasible in trials | We estimated it may take an expected 14 months for PFs to move practices to the highest response options on some of the KDIS items |
| Add similar implementation effectiveness scales | Examine convergent and discriminant validity of KDIS items with other scales |
| Add implementation science outcome variables [ | Increase the robustness of measuring implementation processes and outcomes that can help explain what happened during trial and why |
|
| |
| Examine the factor structure and reliability in larger sample sizes so the clustering of practice facilitators can be accounted for | Determine whether the KDIS items should be used separately or as a summed score |
| Examine predictive validity | Examine the extent to which the KDIS items can predict practice and patient outcomes |
| Develop a KDIS for research use (KDIS-res) that maximizes content validity and psychometric properties | • Content validity can be maximized by developing KDIS-res with input from PFs and primary care practices |